DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Frankel AE, Woo JH, Ahn C. et al.
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.
Blood 2014;
124 (03) 385-392
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.